Newsweek U.S.
  • Business
  • Economics
  • Markets
  • Technology
Go Ad-Free
  • Login
No Result
View All Result
  • Business
  • Economics
  • Markets
  • Technology
No Result
View All Result
Newsweek U.S.
  • GO AD-FREE
  • Login
Home Economics

JPMorgan Halves Stablecoin Growth Forecast to $500 Billion

Marco Sorenson by Marco Sorenson
July 3, 2025
in Economics
JPMorgan Halves Stablecoin Growth Forecast to $500 Billion

JPMorgan reduced its stablecoin market growth predictions to $500 billion for 2028 which represents half of their initial optimistic forecast. The bank explained that stablecoins have not gained sufficient acceptance for everyday payments and their applications extend mainly to cryptocurrency trading activities.

The dollar-pegged tokens show minimal expansion beyond cryptocurrency exchanges and DeFi platforms despite increasing interest from fintechs and banks. The payments sector represents only 6% of stablecoin demand according to JPMorgan which translates to $15 billion.

The firm stated in its Thursday note that stablecoins will not replace traditional money in the foreseeable future. The stablecoin market value stands at $250 billion according to JPMorgan which reflects their concerns about fragmented regulations and slow adoption in the real economy.

The revised projection from JPMorgan stands in direct opposition to Standard Chartered and Bernstein’s previous predictions which forecast stablecoin supply to reach $2 trillion and $4 trillion respectively during the next decade.

The international adoption of stablecoins remains restricted because China along with other nations support their own digital currency initiatives. The Hong Kong-based unit of Ant Group announced its plans to obtain a license for stablecoin issuance.

The GENIUS Act provides regulatory clarity in the United States yet JPMorgan predicts substantial obstacles must be overcome before stablecoins can lead global financial systems.

Tags: JPMorganStablecoin
Previous Post

German Car Exports to U.S. Plunge as Tariffs Bite

Next Post

Summit, AstraZeneca Discuss $15 Billion Cancer Drug Deal

Related Posts

Currency Exchange International increases share buyback program
Business

Currency Exchange International increases share buyback program

Taiwan Lifts 2025 Growth Outlook, Warns on 2026 Slowdown
Economics

Taiwan Lifts 2025 Growth Outlook, Warns on 2026 Slowdown

Trump’s Goldman Attack Sparks Fears of Softer Wall Street Research
Economics

Trump’s Goldman Attack Sparks Fears of Softer Wall Street Research

Hot PPI Data Keeps Fed on Track for Smaller Rate Cut
Economics

Hot PPI Data Keeps Fed on Track for Smaller Rate Cut

US Jobless Claims Edge Lower but Hiring Remains Soft
Economics

US Jobless Claims Edge Lower but Hiring Remains Soft

Goldman Economist Stands Firm After Trump Tariff Criticism
Economics

Goldman Economist Stands Firm After Trump Tariff Criticism

Next Post
Summit, AstraZeneca Discuss $15 Billion Cancer Drug Deal

Summit, AstraZeneca Discuss $15 Billion Cancer Drug Deal

Newsweek U.S.

© 2025 Newsweek U.S. All rights reserved.

Navigate Site

  • Privacy Policy
  • Terms
  • About us
  • Contacts

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business
  • Economics
  • Markets
  • Technology

© 2025 Newsweek U.S. All rights reserved.